US SB1844 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 7 2023 - 25% progression
Action: 2023-07-26 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 7 2023 - 25% progression
Action: 2023-07-26 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.
Title
Animal Drug and Animal Generic Drug User Fee Amendments of 2023 Animal Generic Drug User Fee Amendments of 2023 Animal Drug User Fee Amendments of 2023
Sponsors
| Sen. Tammy Baldwin [D-WI] | Sen. Markwayne Mullin [R-OK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-07-26 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 174. |
| 2023-07-26 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report. |
| 2023-06-15 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment favorably. |
| 2023-06-07 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB1418 (Related) 2023-09-20 - Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
SB1842 (Related) 2023-06-07 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
HB5860 (Related) 2023-09-30 - Motion to reconsider laid on the table Agreed to without objection.
HB6687 (Related) 2023-12-08 - Referred to the Subcommittee on Health.
SB1842 (Related) 2023-06-07 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
HB5860 (Related) 2023-09-30 - Motion to reconsider laid on the table Agreed to without objection.
HB6687 (Related) 2023-12-08 - Referred to the Subcommittee on Health.
